Interferon-α2B, 5-fluorouracil and mitomycin C combination chemotherapy for metastatic renal cell carcinoma

T. Tsushima, M. Noda, Y. Nasu, H. Ohmori, A. Yamamoto, H. Takigawa, S. Kagawa, Y. Matsumura, T. Matsumoto, I. Ogawa, A. Kawano, M. Nishi, S. Akazawa, S. Nakamura, K. Y. Akiyama, K. Tatara, Y. Sumiyoshi, Y. Aga, T. Yokota

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Interferon-α2B, 5-fluorouracil and mitomycin C combination chemotherapy for metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences